CD274 and cervical cancer: The negative correlation between m5C scores and PD-L1 expression, alongside a positive association with tumor mutation burden (TMB), underscores the potential of combining epigenetic therapies with immune checkpoint inhibitors to improve immunotherapy responses in cervical cancer [110].